FGF21 and diabetes mellitus: Another larger scale study showed higher baseline plasma FGF21 levels were associated with higher risk of cardiovascular events in patients with type 2 diabetes over 5 years follow-up in 9,697 individuals with type 2 diabetes participating in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study [41].